Literature DB >> 22473420

A population-based prospective 24-month study of stroke: incidence and 30-day case-fatality rates of first-ever strokes in Croatia.

Slaven Pikija1, Danijel Cvetko, Branko Malojčić, Zlatko Trkanjec, Ivan Pavliček, Anita Lukić, Andrina Kopjar, Martina Hajduk, Alen Andrović, Melita Bilić-Genter, Vladimir Trkulja.   

Abstract

BACKGROUND: In Central/Eastern European countries, cerebrovascular diseases are among the leading causes of mortality. We aimed to determine the incidence of first-ever stroke (FES) in the north-western part of Croatia.
METHODS: A population-based prospective incidence study was conducted between July 1, 2007, and June 30, 2009. Cases were sought from multiple overlapping sources. Incidence rates by stroke type and gender were calculated.
RESULTS: A total of 1,487 events were recorded, 1,017 of which were FESs. European age-adjusted incidence rates (per 100,000 population) were: total FESs 223.6 [women/men rate ratio (w/m RR) = 0.65 (95% CI 0.57-0.73)]; ischemic stroke 162.4 (w/m RR = 0.65, 0.56-0.76); intracerebral hemorrhage 28.4 (w/m RR = 0.44, 0.30-0.63); subarachnoid hemorrhage 7.2 (w/m RR = 1.18, 0.55-2.54); unknown etiology 25.5 (w/m RR = 0.78, 0.54-1.14). Adjusted incidence rates of ischemic strokes by subtype were: cardioembolic 52.9 (w/m RR = 0.77, 0.59-0.99); large-artery atherosclerosis 14.4 (w/m RR = 0.22, 0.13-0.38); small-artery occlusion 24.5 (w/m RR = 0.53, 0.37-0.77) and 'other or uncertain causes' 70.6 (w/m RR = 0.77, 0.62-0.97). Thirty-day case-fatality rate was 23.5% overall and 17.1% for ischemic stroke.
CONCLUSIONS: The incidence of FES and 30-day mortality of patients with ischemic strokes in the studied population is higher than in Western European countries.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22473420     DOI: 10.1159/000336114

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

1.  Statin therapy does not affect the radiographic and clinical profile of patients with TIA and minor stroke.

Authors:  N Asdaghi; J I Coulter; J Modi; M C Camden; A Qazi; M Goyal; T Rundek; S B Coutts
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

2.  Incidence and Long-Term Survival of Spontaneous Intracerebral Hemorrhage Over Time: A Systematic Review and Meta-Analysis.

Authors:  Xianqi Li; Li Zhang; Charles D A Wolfe; Yanzhong Wang
Journal:  Front Neurol       Date:  2022-03-10       Impact factor: 4.003

3.  Epidemiology of intracerebral hemorrhage: A systematic review and meta-analysis.

Authors:  Sai Wang; Xue-Lun Zou; Lian-Xu Wu; Hui-Fang Zhou; Linxiao Xiao; Tianxing Yao; Yupeng Zhang; Junyi Ma; Yi Zeng; Le Zhang
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

4.  A clinical study of transcranial ultrasound as an adjuvant therapy for progressive cerebral infarction.

Authors:  Xiuju Gao
Journal:  Exp Ther Med       Date:  2013-02-19       Impact factor: 2.447

5.  Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.

Authors:  Nicole T A Rosendaal; Marleen E Hendriks; Mark D Verhagen; Oladimeji A Bolarinwa; Emmanuel O Sanya; Philip M Kolo; Peju Adenusi; Kayode Agbede; Diederik van Eck; Siok Swan Tan; Tanimola M Akande; William Redekop; Constance Schultsz; Gabriela B Gomez
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

6.  Stroke in-hospital survival and its predictors: the first results from Tabriz Stroke Registry of Iran.

Authors:  Reza Deljavan; Mehdi Farhoudi; Homayoun Sadeghi-Bazargani
Journal:  Int J Gen Med       Date:  2018-06-19

7.  Prevalence of stroke survival in rural communities living in northern Peru.

Authors:  Luz M Moyano; Silvia M Montano; Percy Vilchez Barreto; Narcisa Reto; Luis Larrauri; Nicanor Mori; Mario Cornejo-Olivas; Erik Guevara-Silva; Fernando Urizar; Enrique Najar; Ricardo Gamboa; Cintya Azabache; Raquel Herrer Ticse; Lucia Bolivar-Herrada; Alex Doud; Peggy Martinez; J Jaime Miranda; Joseph R Zunt; Hector H García
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.